Page last updated: 2024-09-05

organophosphonates and Cytomegalovirus Infections

organophosphonates has been researched along with Cytomegalovirus Infections in 146 studies

Research

Studies (146)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.68)	18.7374
1990's	59 (40.41)	18.2507
2000's	55 (37.67)	29.6817
2010's	30 (20.55)	24.3611
2020's	1 (0.68)	2.80

Authors

Authors	Studies
Bernstein, DI; Cardin, RD; Chadderdon, AM; Doherty, MK; Domagala, JM; Gan, X; Harden, EA; Harteg, CC; Hartline, CB; Hutchings, KM; James, SH; Keith, KA; Lipka, E; Prichard, MN; Reyna, DM; Simon, ES; Spencer, JF; Tollefson, AE; Toth, K; White, AD; Wold, WSM	1
Bar-On, S; Haynes, RK; Lantsberg, D; Laskov, I; Oiknine-Djian, E; Panet, A; Wolf, DG	1
Bruminhent, J; Rotjanapan, P; Watcharananan, SP	1
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L	1
Frange, P; Leruez-Ville, M	1
DeVita, AV; Gentry, BG; Markovich, KC; O'Brien, MS; Selleseth, D; Sethna, P	1
Boeckh, MJ; Brundage, TM; Chemaly, RF; Chittick, G; Foster, SA; Marty, FM; Morrison, ME; Mullane, KM; Nichols, WG; Papanicolaou, GA; Shore, TB; Wilson, C; Winston, DJ	1
Hartline, CB; James, SH; Lanier, ER; Price, NB; Prichard, MN	1
Boeckh, M; Brundage, TM; Godkin, S; Marty, FM; Momméja-Marin, H; Mullane, KM; Papanicolaou, GA; Robertson, AT; Rowley, SD; Vance, E; Winston, DJ	1
Fischer, L; Göhring, K; Hamprecht, K; Jahn, G; Laib Sampaio, K	1
Choo, DI; Nassar, M; Reece, AL; Sidell, DR; Ward, JA	1
Gregg, K; Hakki, M; Kaul, DR	1
Peggs, KS; Sellar, RS	1
Chou, S; Ercolani, RJ; Lefterova, MI; Pinsky, BA; Sahoo, MK; Strasfeld, LM	1
Griffiths, P; Lumley, S	1
Boeckh, M; Murphy, WJ; Peggs, KS	1
Boruchov, AM; Chittick, G; Glezerman, IG; Lee, YJ; Momméja-Marin, H; Papanicolaou, GA; Seshan, SV; Young, JW	1
Braverman, RS; Caruso Brown, AE; Cohen, MN; Giller, R; Levin, MJ; Rooney, JF; Tong, S	1
Iapadre, G; Lasorella, S; Mareri, A; Maresca, M; Nigro, G; Tambucci, R	1
Fischer, L; Göhring, K; Hamprecht, K; Jahn, G; Sampaio, KL	1
Chou, S; Ercolani, RJ; Lanier, ER	1
Fischer, L; Göhring, K; Hamprecht, K; Hofmann, J; Imrich, E; Jahn, G; Sampaio, KL	1
Gerna, G; Lilleri, D	1
Ariza-Heredia, EJ; Chemaly, RF; El Chaer, F; El-Haddad, D; Gulbis, AM; Mulanovich, VE; Shah, DP; Shpall, EJ; Vanichanan, J	1
Alain, S; Béné, J; Cannesson, O; Dewilde, A; Faure, E; Galperine, T; Gnemmi, V; Goeminne, C; Lasri, M; Lessore de Sainte Foy, C; Lionet, A	1
Boucher, HW; Torres-Madriz, G	1
Benedetti, E; Ceccherini-Nelli, L; Focosi, D; Galimberti, S; Maggi, F; Papineschi, F; Petrini, M; Pistolesi, D	1
Cinek, O; Formankova, R; Hubacek, P; Keslova, P; Lochmanova, J; Pochop, P; Sedlacek, P; Stary, J; Zajac, M	1
Járay, J; Péter, A; Telkes, G; Varga, M	1
Bunjes, D; Härter, G; Mertens, T; Michel, D; Schreiber, A; Schubert, A	1
Baba, HA; Gerken, G; Kahraman, A; Maldonado-Lopez, E; Miller, M; Treichel, U	1
Cowan, MJ; Dvorak, CC; Horn, B; Weintrub, PS	1
Chou, S; Lurain, NS	1
Beadle, JR; Bernstein, DI; Bravo, FJ; Cardin, RD; Hostetler, KY	1
Kern, ER; Prichard, MN	1
Bowlin, TL; Chou, S; Marousek, G	1
Hong, JH; Kim, E; Li, H; Yoo, JC	1
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H	1
Kimberlin, DW	1
Zaia, JA	2
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M	1
De Clercq, E; Snoeck, R	1
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J	1
Baldanti, F; Campanini, G; Comolli, G; Gerna, G; Lilleri, D; Ridolfo, AL; Rusconi, S	1
Alain, S; Belloc, S; Brouet, JC; Ducancelle, A; Malphettes, M; Mazeron, MC; Petit, F; Sanson Le Pors, MJ; Scieux, C	1
Baldanti, F; Gerna, G; Lurain, N	1
Beadle, JR; Bidanset, DJ; Hostetler, KY; Kern, ER; Wan, WB	1
Meyerle, JH; Turiansky, GW	1
Beadle, JR; Collins, DJ; Hostetler, KY; Kern, ER; Quenelle, DC; Wan, WB	1
Aoki, K; Eto, T; Gondo, H; Harada, M; Henzan, H; Kato, K; Miyamoto, T; Nagafuji, K; Nagatoshi, Y; Obama, K; Ohba, T	1
Buonfrate, D; Cesaro, S; Cusinato, R; Manzardo, C; Mengoli, C; Messina, C; Palù, G; Tridello, G; Zhou, X	1
Beeching, NJ; Douthwaite, ST; Hart, IJ; Mwandumba, HC; Stow, R; Taegtmeyer, M	1
Goh, CL; Tan, HH	1
Choo, DI; Schleiss, MR; Stroup, G; White, DR	1
Chou, S; Rawlinson, WD; Scott, GM; Weinberg, A	1
Abdelhalim, A; Almyroudis, NG; Battiwalla, M; Becker, J; Elefante, A; McCarthy, A; McCarthy, PL; Paplham, P; Segal, BH; Smith, P	1
Aldern, KA; Beadle, JR; Hartline, CB; Hostetler, KY; Keith, KA; Kern, ER; Ruiz, JC	1
Eizuru, Y	1
Ejaz, AA; Kazory, A; Singapuri, S; Wadhwa, A	1
Michaels, MG	1
Bernstein, DI; Bravo, FJ; Cardin, RD	1
Chou, S; Marousek, GI	1
Beadle, JR; Collins, DJ; Hartline, CB; Hostetler, KY; Kern, ER; Pettway, LR; Quenelle, DC; Wan, WB	1
Chou, S; Li, S; Marousek, G; Weinberg, A	1
Cundy, KC; Fisher, PE; Flaherty, J; Hitchcock, MJ; Jaffe, HS; Lalezari, JP; Lietman, PS; Petty, BG; Polis, MA; Wachsman, M	1
Cundy, K; Drew, WL; Fisher, PE; Flaherty, J; Glutzer, E; Hannigan, J; James, C; Lalezari, JP; Martin, JC; Miner, D	1
Baird, BF; Davey, RT; Falloon, J; Fisher, PE; Jaffe, HS; Kovacs, JA; Manischewitz, JF; Polis, MA; Spooner, KM; Walker, RE	1
De Clercq, E; Neyts, J	1
Barnard, DL; Huffman, JH; Reist, EJ; Sidwell, RW	1
Bruggeman, CA; de Clercq, E; Havennith, M; Stals, FS; Zeytinoglu, A	1
Bruggeman, CA; de Clercq, E; Havenith, M; Stals, FS; Zeytinoglu, A	1
De Clercq, E; Neyts, J; Snoeck, R; Sobis, H; Vandeputte, M	1
De Clercq, E	1
Cherrington, JM; Drew, WL; Hitchcock, MJ; Lalezari, JP; Miner, R	1
Chen, MS; Huang, ES; Kim, C; Smith, JL; Xiong, X	1
Jabs, DA	2
Arevalo, JF; Azen, SP; Chavez de la Paz, E; Freeman, WR; Munguia, D; Rahhal, FM	1
Flaherty, JF	1
Danner, SA	1
Drew, WL; Hitchcock, MJ; Jaffe, HS; Lalezari, JP; Stagg, RJ	1
Andrei, G; De Clercq, E; Snoeck, R	1
Barnett, BB; Sidwell, RW; Smee, DF	1
Chen, MS; Cihlar, T	1
Cunningham, ET	2
Eizuru, Y; Harada, K; Ihara, S; Isashiki, Y; Minamishima, Y	1
Davis, JL; Feuer, WJ; Freeman, WR; Leonard, RE; Taskintuna, I; Weinberg, DV	1
Friedberg, DN	1
Blick, G; Garton, T; Hopkins, U; LaGravinese, L	1
Bruggeman, CA; Kloover, JS; Stals, FS; Vanagt, WY	1
Gazzard, BG; Morris-Jones, S; Nelson, M; Sadler, M	1
Arevalo, JF; Banker, AS; Berry, C; De Clercq, E; Freeman, WR; Ishimoto, B; Munguia, D; Ochabski, R; Rahhal, FM; Taskintuna, I	1
Chou, S; Drew, WL; Follansbee, SE; Guentzel, S; Lalezari, JP; Marousek, G; Miner, RC; Poscher, ME	1
Pérez, JL	1
Cherrington, JM; Collier, A; Deeks, SG; Drew, WL; Hellmann, N; Jaffe, HS; Kahn, J; Lalezari, J; Lamy, PD; Li, W; Mulato, AS; Pavia, A; Rodrigue, D; Toole, J	1
Takahashi, K	1
Capparelli, EV; Cundy, KC; Freeman, WR; Rahhal, FM; Taskintuna, I	1
Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ	1
Cinatl, J; Scholz, M; Vogel, JU	1
Avila, CP; Cheng, L; Freeman, WR; Keefe, KS; Macdonald, JC; Rao, NA	1
Fan-Havard, P; Kendle, JB	1
Cheung, TW; Teich, SA	1
Buchanan, J; Davis, LJ	1
Bowen, EF; Cherrington, JM; Emery, VC; Griffiths, PD; Johnson, MA; Lamy, PD	1
Drew, WL; Lalezari, JP	1
Cherrington, J; Jaffe, HS; Safrin, S	1
Cochereau, I; Diraison, MC; Doan, S; Guvenisik, N; Hoang-Xuan, T; Mousalatti, H; Ren, L	1
Blaheta, RA; Cinatl, J; Doerr, HW; Gümbel, HO; Kotchetkov, R; Scholz, M; Vogel, JU; Weimer, E	1
Bolger, G; Bousquet, C; Cordingley, M; Garneau, M; Kibler, P; Lapeyre, N; Rhéaume, M	1
Emery, VC	2
Einsele, H; Hebart, H	1
Biel, SS; Chen, S; Gelderblom, HR; Held, TK; Kurth, A; Nitsche, A; Siegert, W	1
Schmidt, RE; Werwitzke, S; Witte, T	1
Pavesio, C; Scott, RA	1
Distler, A; Ketteler, M; Mertz, A; Offermann, G; Preuschof, L; Schäfer, H; Stöffler-Meilicke, M	1
Bacigalupo, A; Bornhäuser, M; Cesaro, S; Cordonnier, C; Crooks, B; Dekker, A; Deliliers, GL; Einsele, H; Gratecos, N; Klingebiel, T; Ljungman, P; Matthes-Martin, S; Musso, M; Platzbecker, U; Ribaud, P; Tagliaferri, E; Trenschel, R; Ullmann, AJ; Ullmann, J; Wacker, P	1
Castagnola, E; Cristina, E; Dallorso, S; Giacchino, R; Lanino, E	1
Bruggeman, CA; Bruning, JH; De Clercq, E; Lemström, K; Persoons, M; Stals, FS	1
Bandt, D; Bornhäuser, M; Ehninger, G; Freiberg-Richter, J; Geissler, G; Helwig, A; Platzbecker, U; Plettig, R; Rethwilm, A; Schuler, U; Thiede, C	1
Torres, G	1
Alston, B; Brosgart, CL; Chaloner, K; Cohn, DL; El-Sadr, WM; Fisher, EJ; Grant, LB; Sampson, J; Schmetter, B	1
Basara, N; Kiehl, MG	1
Castagnola, E; Chierici, M; Cristina, E; Lanino, E; Miano, M; Morreale, G	1
Alkan, S; Bhorade, SM; Garrity, ER; Husain, AN; McCabe, MA; Norwick, L; Sandesara, C; Vigneswaran, WT; Yeldandi, V	1
Bidanset, DJ; Hartline, CB; Kern, ER; Rybak, RJ	1
Salmon-Ceron, D	1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B	1
Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H	1
Deviatko, E; Graninger, W; Presterl, E; Zedtwitz-Liebenstein, K	1
Chou, SW	1
Bartolozzi, B; Bosi, A; Guidi, S; Orsi, A; Rossi Ferrini, P; Vannucchi, AM	1
Williams, IG	1
Balzarini, J; De Clercq, E; Naesens, L; Neyts, J	1
Holy, A; Leonhardt, JA; Mead, JR; Morris, JL; Sidwell, RW; Smee, DF	1
Kern, ER	1
De Castro, LM; De Clercq, E; Gangemi, JD; Ghaffar, A; Kern, ER; Mayer, EP; Vogt, PE	1
De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R	1
Bruggeman, CA; de Clercq, E; Stals, FS	1
Bronson, JJ; Ferrara, LM; Ghazzouli, I; Hitchcock, MJ; Ho, HT; Kern, ER; Martin, JC; Soike, KF; Woods, KL	1
Feng, JS; Fong, CK; Hsiung, GD; Li, SB; Lucia, HL; Yang, ZH	1
Azuma, M; Sakuma, T	1

Reviews

38 review(s) available for organophosphonates and Cytomegalovirus Infections

Article	Year
Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections. Medecine et maladies infectieuses, 2018, Volume: 48, Issue:8 Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Cytosine; Ganciclovir; Humans; Organophosphonates; Quinazolines; Ribonucleosides	2018
Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update. Expert opinion on biological therapy, 2014, Volume: 14, Issue:8 Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes; Transplant Recipients; Transplantation, Homologous	2014
Cytomegalovirus. Current opinion in infectious diseases, 2014, Volume: 27, Issue:6 Topics: Acetates; Antiviral Agents; Benzimidazoles; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Transmission, Infectious; Double-Blind Method; Female; Ganciclovir; Humans; Male; Organ Transplantation; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Quinazolines; Randomized Controlled Trials as Topic; Ribonucleosides	2014
Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:1 Topics: Acetates; Adoptive Transfer; Animals; Antiviral Agents; Benzimidazoles; Cell- and Tissue-Based Therapy; Clinical Trials, Phase III as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Killer Cells, Natural; Leflunomide; Mice; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes	2015
Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:10 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompetence; Organophosphonates; Treatment Outcome	2016
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients. Immunotherapy, 2016, Volume: 8, Issue:9 Topics: Acetates; Adult; Animals; Antiviral Agents; Asymptomatic Diseases; Benzimidazoles; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Management; Gastroenteritis; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Monitoring, Immunologic; Organophosphonates; Pneumonia; Postoperative Complications; Quinazolines; Ribonucleosides	2016
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Sep-01, Volume: 47, Issue:5 Topics: Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Organ Transplantation; Organophosphonates; Transplantation; Valganciclovir	2008
[Gastrointestinal cytomegalovirus infections in organ transplant patients]. Orvosi hetilap, 2008, Dec-21, Volume: 149, Issue:52 Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir	2008
Antiviral treatment of cytomegalovirus infection and resistant strains. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Thionucleotides; Valganciclovir	2009
Antiviral drug resistance of human cytomegalovirus. Clinical microbiology reviews, 2010, Volume: 23, Issue:4 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genome, Viral; Humans; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Sequence Analysis, DNA	2010
The search for new therapies for human cytomegalovirus infections. Virus research, 2011, Volume: 157, Issue:2 Topics: Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Guanine; Humans; Organophosphonates; Valganciclovir; Virus Replication	2011
Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone marrow transplantation, 2002, Volume: 29, Issue:8 Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Risk Factors	2002
[Drugs against human cytomegalovirus]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine	2002
Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:11 Topics: Cidofovir; Cytomegalovirus Infections; Cytosine; DNA Virus Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds	2002
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:9 Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning	2003
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Human immunology, 2004, Volume: 65, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication	2004
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. American journal of clinical dermatology, 2006, Volume: 7, Issue:1 Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine	2006
[Mechanism of drug-resistance in human cytomegalovirus]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins	2007
Treatment of congenital cytomegalovirus: where are we now? Expert review of anti-infective therapy, 2007, Volume: 5, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Valganciclovir	2007
Antivirals for the treatment of herpesvirus infections. The Journal of antimicrobial chemotherapy, 1993, Volume: 32 Suppl A Topics: Acyclovir; Antiviral Agents; Belgium; Bromodeoxyuridine; Cidofovir; Cytomegalovirus Infections; Cytosine; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds	1993
Management of cytomegalovirus disease. AIDS (London, England), 1995, Volume: 9 Suppl 2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Foscarnet; Ganciclovir; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds	1995
A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC). Advances in experimental medicine and biology, 1996, Volume: 394 Topics: Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds	1996
Cidofovir. Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:6 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis	1997
Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance. Microbiologia (Madrid, Spain), 1997, Volume: 13, Issue:3 Topics: Antiviral Agents; Cidofovir; Codon; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Viral Structural Proteins	1997
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7]. Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Purines; Thymidine Kinase	1998
Treatment of cytomegalovirus diseases. Intervirology, 1997, Volume: 40, Issue:5-6 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1997
Cidofovir in the treatment of cytomegaloviral disease. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:11 Topics: Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Interactions; Humans; Organophosphonates; Organophosphorus Compounds	1998
Cytomegalovirus infection in patients with HIV infection. The Mount Sinai journal of medicine, New York, 1999, Volume: 66, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds	1999
Cytomegalovirus: disease syndromes and treatment. Current clinical topics in infectious diseases, 1999, Volume: 19 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Diseases; Chorioretinitis; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds; Pneumonia; Sexually Transmitted Diseases, Viral	1999
Cidofovir. Review of current and potential clinical uses. Advances in experimental medicine and biology, 1999, Volume: 458 Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Humans; Organophosphonates; Organophosphorus Compounds	1999
Cytomegalovirus drug resistance. Antiviral therapy, 1998, Volume: 3, Issue:4 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Organophosphorus Compounds	1998
Uveitis in HIV positive patients. The British journal of ophthalmology, 2000, Volume: 84, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; HIV Seropositivity; Humans; Organophosphonates; Organophosphorus Compounds; Rifabutin; Sarcoidosis; Syphilis; Tuberculosis; Uveitis	2000
Cytomegalovirus infection following stem cell transplantation. Haematologica, 1999, Volume: 84 Suppl EHA-4 Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Blood Donors; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunotherapy, Adoptive; Leukocyte Transfusion; Organophosphonates; Organophosphorus Compounds; Premedication; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Latency	1999
Progress in understanding cytomegalovirus drug resistance. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2001, Volume: 21, Issue:3 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Forecasting; Foscarnet; Ganciclovir; Humans; Incidence; Organophosphonates; Organophosphorus Compounds	2001
Cytomegalovirus infection: the point in 2001. HIV medicine, 2001, Volume: 2, Issue:4 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Monitoring; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Population Surveillance; Predictive Value of Tests; Prevalence; Risk Factors; Valganciclovir	2001
Cytomegalovirus drug resistance and clinical implications. Transplant infectious disease : an official journal of the Transplantation Society, 2001, Volume: 3 Suppl 2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Incidence; Organ Transplantation; Organophosphonates; Organophosphorus Compounds; Risk Factors	2001
Management of CMV disease in HIV infection. International journal of STD & AIDS, 1999, Volume: 10, Issue:4 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Foscarnet; Ganciclovir; Gastrointestinal Diseases; Humans; Organophosphonates; Organophosphorus Compounds	1999
Value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplantation proceedings, 1991, Volume: 23, Issue:3 Suppl 3 Topics: Acyclovir; Animals; Antiviral Agents; Cell Division; Cell Survival; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Fibroblasts; Ganciclovir; Humans; Mice; Organophosphonates; Organophosphorus Compounds; Virus Replication	1991

Trials

10 trial(s) available for organophosphonates and Cytomegalovirus Infections

Article	Year
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Allografts; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organophosphonates; Survival Rate	2019
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. The New England journal of medicine, 2013, Sep-26, Volume: 369, Issue:13 Topics: Administration, Oral; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Diarrhea; DNA, Viral; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Organophosphonates; Polymerase Chain Reaction; Transplantation, Homologous	2013
Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Acute Kidney Injury; Adenovirus Infections, Human; Adolescent; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Humans; Male; Organophosphonates; Pilot Projects; Polyomavirus Infections; Viremia	2015
Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2004, Volume: 34, Issue:10 Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Adult; Antiviral Agents; Child; Cidofovir; Cystitis; Cytomegalovirus Infections; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Humans; Male; Middle Aged; Opportunistic Infections; Organophosphonates; Treatment Outcome	2004
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. The Journal of infectious diseases, 1995, Volume: 171, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Creatine; Cytomegalovirus Infections; Cytosine; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Kidney; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Proteinuria; Semen; Virus Shedding	1995
Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug. The Journal of infectious diseases, 1996, Volume: 173, Issue:4 Topics: Adult; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds	1996
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. The Journal of infectious diseases, 1997, Volume: 176, Issue:6 Topics: Adenine; Administration, Oral; Adult; Anti-HIV Agents; Carnitine; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lymphocyte Count; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; RNA, Viral; Semen; Sequence Analysis, RNA; T-Lymphocyte Subsets	1997
Opportunistic infection highlights from the 35th ICAAC. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:10 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia	1995
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial. AIDS (London, England), 2001, Sep-07, Volume: 15, Issue:13 Topics: Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral	2001
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation	2001

Other Studies

98 other study(ies) available for organophosphonates and Cytomegalovirus Infections

Article	Year
NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin. Molecular pharmaceutics, 2023, 01-02, Volume: 20, Issue:1 Topics: Animals; Antiviral Agents; Biological Availability; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Mice; Organophosphonates; Prodrugs	2023
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus. Antiviral research, 2019, Volume: 172 Topics: Acetates; Antiviral Agents; Artemisinins; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Interactions; Drug Synergism; Drugs, Investigational; Female; Ganciclovir; Humans; Organ Culture Techniques; Organophosphonates; Placenta; Pregnancy; Quinazolines; Ribonucleosides	2019
Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand. Transplantation proceedings, 2017, Volume: 49, Issue:5 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mutation; Organ Transplantation; Organophosphonates; Postoperative Complications; Real-Time Polymerase Chain Reaction; Retrospective Studies; Thailand; Young Adult	2017
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. Transplantation proceedings, 2017, Volume: 49, Issue:7 Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors	2017
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus. Antiviral research, 2018, Volume: 158 Topics: Antiviral Agents; Benzimidazoles; Cell Line; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Antagonism; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Endodeoxyribonucleases; Fibroblasts; Foscarnet; Ganciclovir; Guanine; Humans; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Ribonucleosides; Viral Proteins; Virus Replication	2018
Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Cells, Cultured; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Sequence Analysis, DNA	2013
Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation. Antiviral research, 2013, Volume: 100, Issue:3 Topics: Antiviral Agents; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Foscarnet; Ganciclovir; Genes, Viral; Humans; Mutagenesis; Mutation, Missense; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Viral Proteins	2013
Safety of cidofovir by intratympanic delivery technique. Antiviral therapy, 2014, Volume: 19, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cochlea; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing Loss, Sensorineural; Injections; Organophosphonates	2014
UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mutation; Organophosphonates; Viral Proteins	2014
Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Organophosphonates; Pneumonia, Viral; Time Factors; Viral Proteins; Virus Replication	2014
Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 65, Issue:5 Topics: BK Virus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Male; Middle Aged; Organophosphonates; Polyomavirus; Polyomavirus Infections; Tumor Virus Infections; Viremia	2015
Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015, Volume: 69 Topics: Adult; Antiviral Agents; Cell Line; Child; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Female; Ganciclovir; Genotype; Humans; Infant; Male; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins	2015
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Expression; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Protein Domains; Viral Proteins	2016
Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance. Antiviral research, 2016, Volume: 131 Topics: Adolescent; Adult; Antiviral Agents; Child; Chromosomes, Artificial, Bacterial; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Infant; Middle Aged; Mutation; Organophosphonates; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Polymorphism, Genetic; Viral Proteins	2016
Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral research, 2016, Volume: 134 Topics: Aged; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Female; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesviridae Infections; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasms; Organophosphonates	2016
Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection. Medicine, 2016, Volume: 95, Issue:44 Topics: Acute Kidney Injury; Antiviral Agents; Cytomegalovirus Infections; Cytosine; Heart Transplantation; Humans; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Severity of Illness Index	2016
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature. Leukemia research, 2009, Volume: 33, Issue:4 Topics: Administration, Intravesical; Adult; Antineoplastic Agents; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Hematuria; Humans; Hyperbaric Oxygenation; Leukemia, Myeloid, Acute; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections	2009
Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatric transplantation, 2009, Volume: 13, Issue:7 Topics: Adolescent; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Organophosphonates; Retinitis; Treatment Outcome	2009
[A 55-year-old woman with thymoma and hypogammaglobulinemia (Good syndrome), ulcerative colitis, and cytomegalovirus infection]. Medizinische Klinik (Munich, Germany : 1983), 2009, Feb-15, Volume: 104, Issue:2 Topics: Agammaglobulinemia; Antiviral Agents; Azathioprine; Cidofovir; Colitis, Ulcerative; Cytomegalovirus Infections; Cytosine; Enteritis; Female; Humans; Immunization, Passive; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Leukopenia; Middle Aged; Mycophenolic Acid; Neoplasm Staging; Opportunistic Infections; Organophosphonates; Postoperative Complications; Syndrome; Thymectomy; Thymoma; Thymus Neoplasms	2009
Development of herpes simplex virus stomatitis during receipt of cidofovir therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Oct-15, Volume: 49, Issue:8 Topics: Acyclovir; Antiviral Agents; Chemoprevention; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Ganciclovir; Humans; Male; Organophosphonates; Simplexvirus; Stem Cell Transplantation; Stomatitis; Treatment Outcome	2009
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Administration, Oral; Animals; Antiviral Agents; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Organophosphonates; Pregnancy; Treatment Outcome	2011
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Alkaline Phosphatase; Antiviral Agents; Cidofovir; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exonucleases; Foscarnet; Ganciclovir; Genes, Reporter; Genotype; Guanine; Humans; Inhibitory Concentration 50; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication	2012
Synthesis of novel difluoro-cyclopropyl guanine nucleosides and their phosphonate analogues as potent antiviral agents. Nucleosides, nucleotides & nucleic acids, 2011, Volume: 30, Issue:11 Topics: Antiviral Agents; Cell Line; Cyclopropanes; Cytomegalovirus; Cytomegalovirus Infections; Guanine; Halogenation; HIV Infections; HIV-1; Humans; Nucleosides; Organophosphonates	2011
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient. Transplantation, 2012, Apr-15, Volume: 93, Issue:7 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome	2012
Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Time Factors	2002
Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Oct-15, Volume: 35, Issue:8 Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Valacyclovir; Valganciclovir; Valine	2002
Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:3 Topics: Antigens, Viral; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cidofovir; Cytokines; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Resistance, Viral; Ganciclovir; Humans; Immunity, Cellular; Lung; Lung Transplantation; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds	2004
Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:4 Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, T-Cell; Molecular Epidemiology; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA	2004
Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection. The Journal of infectious diseases, 2004, Aug-01, Volume: 190, Issue:3 Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Esters; Ether; Humans; Lipids; Male; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Prodrugs; Treatment Outcome	2004
Perianal ulcer in a patient with AIDS. Archives of dermatology, 2004, Volume: 140, Issue:7 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differential; Fatal Outcome; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Perineum; Skin Ulcer	2004
Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esters; Female; Injections, Intraperitoneal; Injections, Intravenous; Lipids; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Structure-Activity Relationship; Viral Load	2004
Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 34, Issue:2 Topics: Adolescent; Antigens, Viral; Antiviral Agents; Child; Cidofovir; Creatinine; Cytomegalovirus Infections; Cytosine; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphonates; Premedication; Virus Activation	2005
Cidofovir treatment of HIV-associated cytomegalovirus polyradiculopathy. AIDS (London, England), 2006, Feb-28, Volume: 20, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Female; Humans; Organophosphonates; Polyradiculopathy	2006
The effect of cidofovir on cytomegalovirus-induced hearing loss in a Guinea pig model. Archives of otolaryngology--head & neck surgery, 2006, Volume: 132, Issue:6 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Evoked Potentials, Auditory; Guinea Pigs; Hearing Loss; Organophosphonates; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction	2006
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Multiple; Drug Resistance, Viral; Foscarnet; Ganciclovir; Genotype; Humans; Immunocompromised Host; Mutation; Organophosphonates; Phenotype; Viral Proteins; Virus Replication	2007
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Fatal Outcome; Ganciclovir; Hodgkin Disease; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Renal Insufficiency; Secondary Prevention; Treatment Failure; Virus Activation	2007
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir. Antiviral research, 2007, Volume: 75, Issue:1 Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cowpox; Cytomegalovirus Infections; Cytosine; Herpes Simplex; HIV-1; Humans; In Vitro Techniques; Molecular Structure; Organophosphonates; Sensitivity and Specificity; Vaccinia	2007
Simultaneous development of Fanconi syndrome and acute renal failure associated with cidofovir. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Acute Kidney Injury; Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Fanconi Syndrome; Humans; Male; Organophosphonates	2007
A model of human cytomegalovirus infection in severe combined immunodeficient mice. Antiviral research, 2007, Volume: 76, Issue:2 Topics: Animals; Antiviral Agents; Cell Culture Techniques; Cell Line; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Gelatin Sponge, Absorbable; Humans; Male; Mice; Mice, SCID; Organophosphonates; Viral Plaque Assay	2007
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant. Journal of virology, 2008, Volume: 82, Issue:1 Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Benzimidazoles; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Models, Molecular; Molecular Sequence Data; Mutant Proteins; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Ribonucleosides; Sequence Alignment; Viral Proteins	2008
Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models. Antiviral research, 2008, Volume: 79, Issue:2 Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Mice, SCID; Muromegalovirus; Organophosphonates; Survival Analysis	2008
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2008, Volume: 43, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phenotype; Protein Structure, Tertiary; Viral Proteins	2008
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Immunocompromised Host; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid	1995
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:4 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Urine	1995
New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1994, Volume: 56, Issue:6 Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Ganciclovir; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication	1994
Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine. Antiviral research, 1993, Volume: 22, Issue:1 Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Fibroblasts; Ganciclovir; Guinea Pigs; Humans; Mice; Mice, Inbred BALB C; Muromegalovirus; Organophosphonates; Stereoisomerism; Time Factors; Viral Plaque Assay	1993
Comparative effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine treatment on cytomegalovirus-induced interstitial pneumonitis in allogeneic bone marrow transplant recipient rats. Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2 Topics: Animals; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytomegalovirus Infections; Cytosine; Ganciclovir; Male; Organophosphonates; Organophosphorus Compounds; Pulmonary Fibrosis; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Whole-Body Irradiation	1993
Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:2 Topics: Animals; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Immunohistochemistry; Lung; Male; Organophosphonates; Organophosphorus Compounds; Paraffin Embedding; Pneumonia, Viral; Rats; Whole-Body Irradiation	1993
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:4 Topics: Animals; Animals, Newborn; Antiviral Agents; Brain; Brain Diseases; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Ganciclovir; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds	1993
Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochemical pharmacology, 1996, Jun-14, Volume: 51, Issue:11 Topics: Animals; Antiviral Agents; Base Sequence; Cattle; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA; Fibroblasts; Humans; Kinetics; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Viral Proteins	1996
Treatment of cytomegalovirus retinitis in patients with AIDS. Annals of internal medicine, 1996, Jul-15, Volume: 125, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Routes; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Retinitis	1996
Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report. Annals of internal medicine, 1996, Jul-15, Volume: 125, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Progression; Female; Humans; Injections, Intralesional; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinitis; Treatment Outcome; Vitreous Body	1996
Current and experimental therapeutic options for cytomegalovirus disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Apr-15, Volume: 53, Issue:8 Suppl 2 Topics: Administration, Oral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Preparations; Foscarnet; Ganciclovir; Guanine; Humans; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds	1996
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:7 Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Lung; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid	1996
Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections. Antiviral research, 1996, Volume: 32, Issue:3 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Ganciclovir; Immunotoxins; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Ricin; Tumor Cells, Cultured	1996
Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Molecular pharmacology, 1996, Volume: 50, Issue:6 Topics: Antiviral Agents; Catalysis; Cell Line; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Kinetics; Organophosphonates; Organophosphorus Compounds; Phosphorylation; Phosphotransferases	1996
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. The Western journal of medicine, 1997, Volume: 166, Issue:2 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Prognosis; Retinitis	1997
Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Archives of virology, 1997, Volume: 142, Issue:2 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Resistance, Microbial; Ganciclovir; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Sequence Analysis, DNA	1997
Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:6 Topics: Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Infections; Cytosine; Female; Humans; Injections, Intravenous; Iritis; Male; Middle Aged; Muscle Tonus; Muscular Diseases; Oculomotor Muscles; Organophosphonates; Organophosphorus Compounds; Retinitis; Retrospective Studies	1997
Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis. Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:6 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Injections, Intravenous; Male; Muscle Tonus; Muscular Diseases; Oculomotor Muscles; Organophosphonates; Organophosphorus Compounds; Retinitis	1997
Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, May-01, Volume: 15, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; Esophagitis; Humans; Male; Organophosphonates; Organophosphorus Compounds; Retinitis	1997
Effective treatment of experimental cytomegalovirus-induced encephalo-meningitis in immunocompromised rats with HPMPC. Antiviral research, 1997, Volume: 35, Issue:2 Topics: Animals; Antiviral Agents; Brain; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Therapy, Combination; Ganciclovir; Immune Sera; Immunocompromised Host; Male; Meninges; Meningitis, Viral; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Inbred BN; Time Factors	1997
Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir. AIDS (London, England), 1997, Volume: 11, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Humans; Magnetic Resonance Imaging; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome	1997
Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. American journal of ophthalmology, 1997, Volume: 124, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Anterior Chamber; Antiviral Agents; Aqueous Humor; Cidofovir; Ciliary Body; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Female; Fluorophotometry; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinitis; Ultrasonography; Vitreous Body	1997
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. The Journal of infectious diseases, 1997, Volume: 176, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Male; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Recombination, Genetic; RNA-Directed DNA Polymerase; Sequence Analysis, DNA	1997
Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1998, Volume: 14, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Infections; Cytosine; Humans; Injections; Injections, Intravenous; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Osmolar Concentration; Prospective Studies; Retinitis; Vitreous Body	1998
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Archives of internal medicine, 1998, May-11, Volume: 158, Issue:9 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Lung Diseases; Nervous System Diseases; Organophosphonates; Organophosphorus Compounds; Retinitis	1998
Cytomegalovirus iritis. Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:11 Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Fatal Outcome; Humans; Immunohistochemistry; Iris; Iritis; Male; Organophosphonates; Organophosphorus Compounds	1998
Comment: cidofovir in the treatment of cytomegaloviral disease. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:6 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Organophosphonates; Organophosphorus Compounds	1999
Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy. Journal of medical virology, 1999, Volume: 58, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Ganciclovir; Genotype; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Prospective Studies; Retinitis; Viral Load; Viral Proteins	1999
Uveitis in patients treated with intravenous cidofovir. Ocular immunology and inflammation, 1999, Volume: 7, Issue:3-4 Topics: Adult; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; HIV Seropositivity; Humans; Injections, Intravenous; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retinitis; Retrospective Studies; Uveitis	1999
The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts. Journal of medical virology, 2000, Volume: 60, Issue:3 Topics: Antiviral Agents; Cells, Cultured; Chemotaxis, Leukocyte; Cidofovir; Cytomegalovirus Infections; Cytosine; Fibroblasts; Foscarnet; Ganciclovir; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-8; Neutrophils; Oligonucleotides, Antisense; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides; Up-Regulation	2000
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis. Antiviral research, 1999, Dec-31, Volume: 44, Issue:3 Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Body Weight; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Ganciclovir; Hepatitis, Viral, Animal; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication	1999
Adefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA. Drugs in R&D, 1999, Volume: 2, Issue:5 Topics: Adenine; Animals; Anti-HIV Agents; Biological Availability; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Drugs, Investigational; HIV Infections; Humans; Macaca fascicularis; Male; Organophosphonates; Protein Binding; Randomized Controlled Trials as Topic; Semen	1999
Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone marrow transplantation, 2000, Volume: 26, Issue:3 Topics: Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematuria; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Virus Activation	2000
CMV complications in common variable immunodeficiency. Immunobiology, 2000, Volume: 202, Issue:2 Topics: Adult; Antiviral Agents; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cidofovir; Colitis; Common Variable Immunodeficiency; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Cytotoxicity Tests, Immunologic; Encephalitis, Viral; Female; Foscarnet; Humans; K562 Cells; Killer Cells, Natural; Myelitis; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Viral Matrix Proteins	2000
Ocular side-effects from systemic HPMPC (Cidofovir) for a non-ocular cytomegalovirus infection. American journal of ophthalmology, 2000, Volume: 130, Issue:1 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Probenecid; Uveitis, Anterior	2000
Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient. Clinical nephrology, 2000, Volume: 54, Issue:5 Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pneumonia, Viral; Polymerase Chain Reaction; Postoperative Complications	2000
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood, 2001, Jan-15, Volume: 97, Issue:2 Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Data Collection; Drug Evaluation; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Retrospective Studies; Survival Rate; Transplantation, Homologous; Treatment Outcome	2001
Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:1 Topics: Adenoviridae; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Evaluation; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome	2001
Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant international : official journal of the European Society for Organ Transplantation, 1994, Volume: 7 Suppl 1 Topics: Animals; Antiviral Agents; Aorta; Arteriosclerosis; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Graft Rejection; Male; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima; Tunica Media; Virus Replication	1994
Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation. Transplantation, 2001, Apr-15, Volume: 71, Issue:7 Topics: Adult; Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Myeloablative Agonists; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Preventive Medicine; Prospective Studies; Transplantation Conditioning; Viral Matrix Proteins	2001
Advances, challenges and growing frustration. PI perspective, 1995, Issue:no 16 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cachexia; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Costs; Drug Therapy, Combination; Growth Hormone; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Immunity, Cellular; Infectious Disease Transmission, Vertical; Organophosphonates; Organophosphorus Compounds; Politics; Reverse Transcriptase Inhibitors; Zidovudine	1995
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphoproteins; Recurrence; Salvage Therapy; Time Factors; Transplantation, Homologous; Viral Matrix Proteins; Viremia	2001
Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2001, Volume: 20, Issue:9 Topics: Adult; Antiviral Agents; Cell Culture Techniques; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Female; Ganciclovir; Humans; Illinois; Immunization, Passive; Lung Transplantation; Male; Middle Aged; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Predictive Value of Tests; Prospective Studies; Reagent Kits, Diagnostic; Sensitivity and Specificity; Survival Analysis; Syndrome; Viral Load	2001
Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections. Antiviral chemistry & chemotherapy, 2001, Volume: 12 Suppl 1 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Humans; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds; Virus Replication	2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient. Bone marrow transplantation, 2001, Volume: 28, Issue:8 Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation	2001
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting	2001
Acute renal failure in a lung transplant patient after therapy with cidofovir. Transplant international : official journal of the European Society for Organ Transplantation, 2001, Volume: 14, Issue:6 Topics: Acute Kidney Injury; Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Lung Transplantation; Male; Organophosphonates; Organophosphorus Compounds	2001
Polymerase chain reaction-based "pre-emptive" therapy with cidofovir for cytomegalovirus reactivation in allogeneic hematopoietic stem cells transplantation recipients: a prospective study. Haematologica, 2002, Volume: 87, Issue:4 Topics: Adult; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prospective Studies; Virus Activation	2002
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. Journal of medical virology, 1992, Volume: 37, Issue:1 Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ganciclovir; Male; Mice; Mice, SCID; Organophosphonates; Organophosphorus Compounds	1992
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9 Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Combinations; Ganciclovir; Immunologic Deficiency Syndromes; Interferon Type I; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Organophosphonates; Organophosphorus Compounds; Recombinant Proteins	1992
Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS. Antiviral research, 1991, Volume: 16, Issue:1 Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Ganciclovir; Herpes Simplex; Immune Tolerance; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds	1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents. Journal of virological methods, 1991, Volume: 35, Issue:1 Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin	1991
Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:11 Topics: Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Guanosine Triphosphate; Humans; Male; Organophosphonates; Organophosphorus Compounds; Rats; Viral Plaque Assay; Virus Replication	1991
(S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent. Advances in experimental medicine and biology, 1990, Volume: 278 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytomegalovirus Infections; Cytosine; Herpesviridae Infections; Mice; Molecular Structure; Organophosphonates; Organophosphorus Compounds	1990
Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs. Antiviral research, 1990, Volume: 13, Issue:5 Topics: Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Guinea Pigs; Organ Specificity; Organophosphonates; Organophosphorus Compounds; Viral Plaque Assay; Virus Replication	1990
[Chemotherapy of cytomegalovirus infections]. Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2 Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid	1989